Physician profile
Steven T Plomaritis
NPI 1235121138
$1,123.66
in general payments reported to CMS, 2019-2025
8 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2022: $295 · 2023: $15.74 · 2024: $423 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505 · Travel and Lodging: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.89 |
| Travel and Lodging | $211.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $243.21 | 2023-2024 | |
| Smith+Nephew, INC. | $228.93 | 2022 | |
| Arthrex, INC. | $160.95 | 2024 | |
| Zimmer Biomet Holdings, INC. | $160.44 | 2019-2022 | |
| Anika Therapeutics, INC. | $153.57 | 2025 | Tactoset |
| Aimmune Therapeutics, INC. | $124.71 | 2025 | Zenpep |
| Stryker Corporation | $34.25 | 2024 | Mako |
| Avanos Medical | $17.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Plomaritis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.